
B&A Biomedical is a Marseille-based startup specializing in advanced data analysis solutions for health and biology, leveraging artificial intelligence to transform complex biological and medical data into actionable insights. Founded by Prof. Yehezkel Ben-Ari, the company develops customized analytical pipelines and AI-powered tools for prognosis, diagnosis, personalized medicine, clinical research optimization, and medical image analysis. Their expertise spans machine learning, deep learning, and sophisticated modeling techniques applied to structured datasets and complex imaging data such as MRI and microscopy. B&A Biomedical also conducts in-house research projects focused on neurodevelopmental and pathological events during in utero and perinatal stages, positioning itself at the forefront of biomedical innovation with a multidisciplinary team combining biology, neuroscience, mathematics, and AI.

B&A Biomedical is a Marseille-based startup specializing in advanced data analysis solutions for health and biology, leveraging artificial intelligence to transform complex biological and medical data into actionable insights. Founded by Prof. Yehezkel Ben-Ari, the company develops customized analytical pipelines and AI-powered tools for prognosis, diagnosis, personalized medicine, clinical research optimization, and medical image analysis. Their expertise spans machine learning, deep learning, and sophisticated modeling techniques applied to structured datasets and complex imaging data such as MRI and microscopy. B&A Biomedical also conducts in-house research projects focused on neurodevelopmental and pathological events during in utero and perinatal stages, positioning itself at the forefront of biomedical innovation with a multidisciplinary team combining biology, neuroscience, mathematics, and AI.
Location: Marseille, France
Core focus: AI-driven biomedical data analysis and medical image analysis
Founders / Leadership: Yehezkel Ben-Ari (President); Constance Hammond (General Director)
Legal form / registration: SAS, SIREN 882962566
Biomedical data interpretation, medical image analysis, prognosis and personalized treatment support in neurology and psychiatry.
2014
Biotechnology
A funding/assistance entry is recorded with a date of 2021-04-01 and Incubateur Impulse noted as an investor/participant.